1,136 results on '"Weersma, Rinse K"'
Search Results
2. Choice of DNA extraction method affects stool microbiome recovery and subsequent phenotypic association analyses
3. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
4. International consensus statement on microbiome testing in clinical practice
5. Muscle Mass, Muscle Strength, and Health-Related Quality of Life in Kidney Transplant Recipients: Results of the TransplantLines Biobank and Cohort Study
6. Host genetic regulation of human gut microbial structural variation
7. Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients
8. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
9. Health-related quality of life is linked to the gut microbiome in kidney transplant recipients
10. Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
11. Melanoma and microbiota: Current understanding and future directions
12. Central Body Fat Distribution and Kidney Function after Living Kidney Donation
13. The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease
14. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
15. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study
16. Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures
17. Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire
18. Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome
19. Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility
20. Gut microbial DL-endopeptidase alleviates Crohn’s disease via the NOD2 pathway
21. Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma
22. Antibody signatures in inflammatory bowel disease: current developments and future applications
23. Plasma Lead Concentration and Risk of Late Kidney Allograft Failure: Findings From the TransplantLines Biobank and Cohort Studies
24. PUFA-Induced Metabolic Enteritis as a Fuel for Crohn’s Disease
25. Cigarette Smoke Increases Risk for Colorectal Neoplasia in Inflammatory Bowel Disease
26. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
27. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
28. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.
29. Discovery, diversity, and functional associations of crAss-like phages in human gut metagenomes from four Dutch cohorts
30. Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease
31. Gut mucosa dissociation protocols influence cell type proportions and single-cell gene expression levels
32. Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project
33. Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome-wide association study
34. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
35. Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients
36. The long-term genetic stability and individual specificity of the human gut microbiome
37. Non-classical clinical presentation at diagnosis by male celiac disease patients of older age
38. Population-wide diversity and stability of serum antibody epitope repertoires against human microbiota
39. Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases.
40. Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study.
41. Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients.
42. Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation
43. Tissue alarmins and adaptive cytokine induce dynamic and distinct transcriptional responses in tissue-resident intraepithelial cytotoxic T lymphocytes
44. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
45. Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease
46. Gut microbial metabolism of 5-aminosalicylic acid in inflammatory bowel disease
47. Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications
48. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
49. Gut microbiome dysbiosis is not associated with portal vein thrombosis in patients with end-stage liver disease: a cross-sectional study
50. Habitual dietary intake of IBD patients differs from population controls: a case–control study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.